Ever wonder what it would feel like to have invested just $10,000 in Alibaba at its inception, only to watch in awe as it balloons to a colossal $542 billion?
Or to have staked your claim in Bird scooters when they were valued at a mere $25 million, only to witness their valuation catapult to over $2 billion in under a year – a stunning 7,830% increase!
The burning question is: How could anyone have possibly known about these golden opportunities?
One could tirelessly research companies innovating with unique solutions to big problems, analyze market potential, or investigate the track records of the founding team.
Or, one could simply learn how to follow the insiders.
(Clicking here will automatically subscribe you to Steven Place Newsletter)
Insiders hold the keys to the kingdom, with access to confidential, critical information about their companies, such as upcoming FDA approvals, merger and acquisition plans, or drug trial results.
These individuals aren't just trading whizzes; they're insiders – the CEOs, CFOs, and board members who exploit privileged, non-public company information to enrich themselves.
I am referring to leveraging the trust and insight of individuals at the very core of these companies.
Insiders can navigate us through the tumult of the market with clarity, all facilitated by a little-known caveat in SEC rule 10b5-1, making this strategy entirely legal.
I've recently polished off an exclusive report on an emerging AI company that I believe is on the brink of a 10X breakthrough!
Register now to get your hands on my report and learn the secrets of pinpointing Insider stock purchases.
Plus, I'll share insights into an elite group of traders who, since 2003, have achieved 621 profitable trades with zero failures.
By registering, you'll learn:
(Clicking here will automatically subscribe you to Steven Place Newsletter)